Axsome Therapeutics Has Initiated ENGAGE Phase 3 Trial Of Solriamfetol, An Investigational Treatment For Binge Eating Disorder In Adults
Axsome Therapeutics已启动Solriamfetol的ENGAGE三期试验,这是一种治疗成人暴饮暴食症的研究性治疗方法
Axsome Therapeutics Has Initiated ENGAGE Phase 3 Trial Of Solriamfetol, An Investigational Treatment For Binge Eating Disorder In Adults
Axsome Therapeutics已启动Solriamfetol的ENGAGE三期试验,这是一种治疗成人暴饮暴食症的研究性治疗方法
使用浏览器的分享功能,分享给你的好友吧